Literature DB >> 11026923

Colorectal cancer update. Prevention, screening, treatment, and surveillance for high-risk groups.

J H Bond1.   

Abstract

Great advances have been made in understanding the cause and molecular genesis of colorectal cancer. The disease can be prevented by a healthful diet and lifestyle or by resecting the precursor of most of these cancers, the advanced adenomatous polyp. Screening the average-risk population plus special surveillance for high-risk groups now is recommended by evidence-based guidelines. Surgery is highly curative for patients without distant metastases, and adjuvant therapy improves survival in selected patients with advanced cancers.

Entities:  

Mesh：

Year:  2000        PMID： 11026923     DOI： 10.1016/s0025-7125(05)70281-9

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  10 in total

1.  Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study.

Authors:  N Arber; S Kuwada; M Leshno; R Sjodahl; R Hultcrantz; D Rex
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

2.  Dose-dependent reduction of 3,2'-dimethyl-4-aminobiphenyl-derived DNA adducts in colon and liver of rats administered celecoxib.

Authors:  Srivani Ravoori; Yi Feng; Jason R Neale; Jeyaprakash Jeyabalan; Cidambi Srinivasan; David W Hein; Ramesh C Gupta
Journal:  Mutat Res       Date:  2007-09-14       Impact factor: 2.433

3.  Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma.

Authors:  Yasuhiko Kitadai; Takamitsu Sasaki; Toshio Kuwai; Toru Nakamura; Corazon D Bucana; Isaiah J Fidler
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

4.  Post-metallic stent placement bleeding caused by stent-induced ulcers.

Authors:  Chun-Tao Wai; Christopher Khor; Siew-Eng Lim; Khek-Yu Ho
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

Review 5.  Colorectal polyps in the elderly: what should be done?

Authors:  Kenneth Miller; Jerome D Waye
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

6.  Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.

Authors:  Richard Jaszewski; Sabeena Misra; Martin Tobi; Nadeem Ullah; Jo Ann Naumoff; Omer Kucuk; Edi Levi; Bradley N Axelrod; Bhaumik B Patel; Adhip P N Majumdar
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

Review 7.  Management of colorectal cancer.

Authors:  A Leslie; R J C Steele
Journal:  Postgrad Med J       Date:  2002-08       Impact factor: 2.401

8.  Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy.

Authors:  Toshio Kuwai; Toru Nakamura; Takamitsu Sasaki; Yasuhiko Kitadai; Jang-Seong Kim; Robert R Langley; Dominic Fan; Xuemei Wang; Kim-Anh Do; Sun-Jin Kim; Isaiah J Fidler
Journal:  Clin Exp Metastasis       Date:  2008-03-07       Impact factor: 5.150

9.  Inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude mice.

Authors:  Takamitsu Sasaki; Yasuhiko Kitadai; Toru Nakamura; Jang-Seong Kim; Rachel Z Tsan; Toshio Kuwai; Robert R Langley; Dominic Fan; Sun-Jin Kim; Isaiah J Fidler
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

10.  Chemoprevention of colonic polyps with balsalazide: an exploratory, double-blind, placebo-controlled study.

Authors:  Jonathan P Terdiman; Lorin K Johnson; Young S Kim; Marvin H Sleisenger; James R Gum; Ann Hayes; Vivian K Weinberg; Kenneth R McQuaid
Journal:  Dig Dis Sci       Date:  2009-11       Impact factor: 3.199
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.